Harvard Business Review

MARCH 27, 2018

“It’s no good fighting an election campaign on the facts,” Cambridge Analytica’s managing director told an undercover reporter, “because actually it’s all about emotion.” The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power.

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

JANUARY 5, 2018

For example, in 2009 professors Brian Becker, Mark Huselid, and Richard Beatty estimated that in most companies less than 15% of jobs are what they call strategic positions and said management should focus “disproportionate investments” on finding A players for those jobs. Connectors in the middle. High-potential future leaders.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

JUNE 21, 2013

Given the forecasts of uncertain global economic growth, we might expect companies to hold off from hiring new employees and to limit whatever international hiring they do to emerging markets. If, in addition, companies are managing their underperformers out poorly, the costs rise even further. Global business Talent management'

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

NOVEMBER 9, 2011

That's what we found when we studied the top management teams of companies in Europe over the past three years. In several industries, such as consumer goods, financial services, industrial products, and logistics, COOs usually had backgrounds in either managing operations or information technology departments.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

NOVEMBER 24, 2015

Joint value in combinations typically comes from one of four sources: increased scale, expanded scope, improvements in management coordination, and expansion of future options. To make a combination successful, you need to engineer the economies of scale carefully to target the potential source of joint value.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

JULY 7, 2011

The question on the tip of everyone's tongue when this type of nightmare takes hold is, "Why doesn't senior management do something?" The less obvious, but equally culpable, individual is often the manager who fumbles the job of taking this employee to task promptly. I'm at a loss when it comes to managing Cynthia," Roger confessed.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

NOVEMBER 8, 2017

With expanding middle classes demanding more-comprehensive care, governments of these emerging markets are under pressure to invest as chronic disease rates — particularly those related to Western lifestyles — dramatically increase and the average age of their once-young populations begins to rise. Insight Center.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

MARCH 16, 2015

Talent Management. ” Other talent management concerns that were mentioned once include: motivating people through hard times, retention and development, and managing diversity and cultural differences. So the challenge was to have the broad marketing strategies with local adaptations.”

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

JUNE 3, 2013

What kind of signal did this choice send to P&G''s top managers? Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? Using data from the 2012 survey, we also found that boards gave their companies'' very poor grades on talent management.

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. At Nokia, the senior leadership team was for a long time extraordinarily homogenous (mostly men, mostly from Finland, mostly software engineers, mostly educated in Helsinki).

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

OCTOBER 29, 2012

Consider the recent phenomena of shoestring 3D design labs or the biofabrication labs at MIT , which are taking the plunge into synthetic biology with far fewer resources than the genetic engineers at government labs. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

SEPTEMBER 15, 2014

Instead of passive subscribers, it created “communities of friends” who generated new story ideas and collaborated with Fast Company staff to develop themes of the “new management revolution.”. Meanwhile, they’re pragmatic enough to engineer ways for people to gain some direct personal benefits along the way.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. has become a Mecca for international scientists, engineers and business students — particularly those undertaking graduate studies.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park. and the U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Frugal innovations require frugal thinking — an ability to engineer cost?conscious Think Frugally.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

DECEMBER 29, 2015

Our ambition is to put “urban diabetes” — type 2 diabetes in cities — on the agenda for people designing and managing cities and for the global health community. Peer-to-peer networks can play an important role in changing people’s ability to manage their own health and equipping them to live with diabetes.

Health Care 8

Health Care NGO Pharmaceuticals Globalization 8

Harvard Business Review

JULY 16, 2013

And 43% cited technology expertise, HR-talent management, international-global expertise, and succession planning as the skills missing most on their boards. The industry with the greatest skills gap was IT & telecommunications, whose boards are in serious need of international-global expertise and HR-talent management.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. True, emerging market countries are getting better at what they do, and even Europe is on the upswing.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. Some regenerative medicines stimulate our bodies to regrow or repair, so the field can include the use of stem cells for tissue engineering. But the benefits don’t stop there, Novick points out.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8

Harvard Business Review

SEPTEMBER 5, 2016

million managers, first-line supervisors, and administrators in the American workforce in 2014. That works out to one manager and administrator for every 4.7 Overall, managers and administrators made up 17.6% Overall, managers and administrators made up 17.6% Bureau of Labor Statistics, there were 23.8 of the U.S.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

JULY 12, 2011

The key is to manage your multiple partners and not let your relationships run wild. Boston Scientific a few years back launched a secret project to reverse-engineer the technology of its single-source supplier of coronary stents. Global airlines manage their multi-partner alliances carefully to avoid duplicating routes.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

OCTOBER 24, 2014

Here are some of the challenges that I’ve observed: Product management. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

NOVEMBER 20, 2015

He is poised to become the leader in this segment of a multi-billion dollar market. Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

JUNE 23, 2015

As one middle manager told me, “No one was willing to go to management and say, ‘Let’s redeploy everyone, including myself, and do something else because this project isn’t working.'” At IBM, mid-level managers also serve as the first line of defense for cross-functional escalation issues.

Team 8

Team Project Software Engineering 8

Harvard Business Review

OCTOBER 11, 2013

Much as I want to believe that a glaringly good idea will stand on its merits, I have come to realize that just like any product or service, ideas require good marketing if they’re going to reach their intended customers. She also believed that Sanofi’s competitive edge was at risk because of this narrow approach to talent management.

Innovation 11

Innovation Christensen Decisionmaking CTO 11

Harvard Business Review

NOVEMBER 7, 2012

Management thinking is inherently faddish, but there are some favorite themes that never fall out of favor. 3M and Google, among others, have given "innovation time off" to their scientists and engineers. Innovation is one those evergreen themes: it is a rare CEO who doesn't list innovation as one her top four or five priorities.

Company 8

Company Stage-Gate Innovation Bureaucracy 8

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. To illustrate this, consider that patent applications in the U.S.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JULY 20, 2017

This is the challenge for all kinds of disruptors, whether in the auto industry, pharmaceuticals, service industries, or healthcare. DNA genetic testing company 23andMe fell behind on its communications with the FDA, resulting in a temporary ban on marketing the company’s personal genetic screening services to the public.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

JUNE 30, 2014

They went deep into three international firms with reputations for excellence – one a law firm, one a public accounting firm, one a management consultancy – conducting over 100 face-to-face interviews with people working within them. In the words of Empson and Alvehus they have gained “legitimacy to lead through market success.”

Politics 8

Politics Pharmaceuticals Consultative Consensus 8